CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Ranolazine Extended-Release Tablets21-08-2019
21-08-2019
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus announces patient enrollment in EVIDENCES VII Phase 2 clinical trial of Saroglitazar Magnesium in NAFLD with PCOS21-08-2019
CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate19-08-2019
Cadila Healthcare Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Share Certificate12-08-2019
Cadila Healthcare standalone Q1 net down 75%
Cadila Healthcare Ltd posted standalone net profit of Rs 79 crore for the quarter ended June 2019, sharply down by about 75 per cent from Rs 310 cro10-08-2019
CADILA HEALTHCARE LTD. - 532321 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here10-08-2019
Cadila Healthcare Ltd - 532321 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Srutinizer''s Report on voting for 24th AGM.09-08-2019
CADILA HEALTHCARE LTD. - 532321 - Voting Results Under Regulation 44(3)
Voting Results under Regulation 44(3)09-08-2019
CADILA HEALTHCARE LTD. - 532321 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Announcement of Results by Chairman.09-08-2019
CADILA HEALTHCARE LTD. - 532321 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 24th AGM09-08-2019